Biomedical and Biotechnology Research Journal (BBRJ)

REVIEW ARTICLE
Year
: 2021  |  Volume : 5  |  Issue : 3  |  Page : 245--251

A review on biomarkers in clinical osteoporosis - Significance of hydroxyproline


Soumya Adugani1, Gurupadayya Bannimath1, Purushothama Sastry2 
1 Department of Pharmaceutical Chemistry, JSS College of Pharmacy, JSS Academy of Higher Education and Research, Mysuru, Karnataka, India
2 Department of Orthopedics, JSS Medical College and Hospital, JSS Academy of Higher Education and Research, Mysuru, Karnataka, India

Correspondence Address:
Dr. Gurupadayya Bannimath
Department of Pharmaceutical Chemistry, JSS College of Pharmacy, JSS Academy of Higher Education and Research, Mysuru - 570 015, Karnataka
India

Osteoporosis is a chronic disorder in both men and women, where it decreases the bone quality and quantity, which may lead to a fall in bone mass density. It mostly occurs because of reduced peak bone mass or excessive formation or resorption during bone remodeling. Various degradation products of bone collagen are pyridinoline (Pyr), deoxypyridinoline, N-terminal telopeptides, and hydroxyproline (Hyp), which are excreted in the urine. Among that, Hyp is a crucial biomarker used to correlate osteoporosis condition. An overview of all the biomarkers and the signed note of Hyp with different analytical methods are provided in the current piece of work. To quantify amounts in biological samples, various methods have been developed for Hyp analysis, such as the colorimetric technique, gas chromatography, gas chromatography-mass spectrometry, and widely used high-performance liquid chromatography tests to detect the concentration of Hyp in different matrices. This review states the importance of biomarkers and Hyp's significance for detecting osteoporosis, clinical manifestation, and different analytical methods for Hyp. The study indicates that hydroxyproline is a unique biomarker used to detect osteoporosis. It is also showing the clinical manifestation of osteoporosis and discussed different analytical methods for hydroxyproline.


How to cite this article:
Adugani S, Bannimath G, Sastry P. A review on biomarkers in clinical osteoporosis - Significance of hydroxyproline.Biomed Biotechnol Res J 2021;5:245-251


How to cite this URL:
Adugani S, Bannimath G, Sastry P. A review on biomarkers in clinical osteoporosis - Significance of hydroxyproline. Biomed Biotechnol Res J [serial online] 2021 [cited 2021 Dec 1 ];5:245-251
Available from: https://www.bmbtrj.org/article.asp?issn=2588-9834;year=2021;volume=5;issue=3;spage=245;epage=251;aulast=Adugani;type=0